- Anemia
- Medication Causes of Macrocytic Anemia
- Vitamin B12 Supplementation
- Erythropoietin
- Darbepoetin Alfa
- Epoetin Alfa
- Methoxy Polyethyelene Glycol Epoetin Beta
- Iron Supplementation
- Parenteral Iron
- Iron Ingestion
- Cancer
- Chemotherapy
- Cytokine Release Syndrome
- Tumor Lysis Syndrome
- Alkylating Agent
- Thiotepa
- Busulfan
- Bendamustine
- Chlorambucil
- Cyclophosphamide
- Ifosfamide
- Mechlorethamine
- Melphalan
- Carmustine
- Streptozocin
- Lomustine
- Carboplatin
- Cisplatin
- Oxaliplatin
- Trabectedin
- Dacarbazine
- Procarbazine
- Temozolomide
- Antibiotic Chemotherapy
- Bleomycin
- Dactinomycin
- Daunorubicin
- Doxorubicin
- Liposomal Doxorubicin
- Epirubicin
- Idarubicin
- Mitomycin
- Mitoxantrone
- Valrubicin
- Hormonally Active Chemotherapy
- Nonsteroidal Antiandrogen
- Abiraterone
- Antimetabolite Chemotherapy
- Azacitidine
- Cytarabine
- Decitabine
- Gemcitabine
- Pemetrexed
- Pralatrexate
- Belinostat
- Panobinostat
- Romidepsin
- Vorinostat
- Hydroxyurea
- Cladribine
- Clofarabine
- Fludarabine
- Mercaptopurine
- Nelarabine
- Pentostatin
- Thioguanine
- Capecitabine
- Floxuridine
- Fluorouracil
- Trifluridine-Tipiracil
- Mitotic Inhibitor Chemotherapy
- Eribulin
- Ixabepilone
- Cabazitaxel
- Docetaxel
- Paclitaxel
- Albumin-Bound Paclitaxel
- Etoposide
- Irinotecan
- Irinotecan Liposome
- Topotecan
- Vinblastine
- Vincristine
- Vincristine Sulfate Liposome
- Vinorelbine
- Arsenic Trioxide
- Asparaginase
- Mitotane
- Porfimer
- Proteasome Inhibitor
- Thalidomide
- Bexarotene
- Systemic Tretinoin
- Targeted Cancer Therapy
- CAR T-Cell Therapy
- Monoclonal Antibody-Mediated Chemotherapy
- CCR4 Monoclonal Antibody
- CD20 Monoclonal Antibody
- Rituximab
- CD22 Monoclonal Antibody
- CD25 Monoclonal Antibody
- CD30 Monoclonal Antibody
- CD33 Monoclonal Antibody
- CD38 Monoclonal Antibody
- CD52 Monoclonal Antibody
- Immune Checkpoint Inhibitor
- CTLA-4 Monoclonal Antibody
- PD-1 Monoclonal Antibody
- PDL-1 Monoclonal Antibody
- GD2 Monoclonal Antibody
- EGFR Monoclonal Antibody
- Anti-HER2 Monoclonal Antibody
- VEGFR Monoclonal Antibody
- Small Molecule Inhibitor-Mediated Chemotherapy
- ALK Inhibitor
- BCL2 Inhibitor
- BCR-ABL Inhibitor
- BRAF Inhibitor
- BTK Inhibitor
- Cyclin-Dependent Kinase Inhibitor
- c-KIT Inhibitor
- EGFR Inhibitor
- FGR2/3 Inhibitor
- FLT3 Inhibitor
- IDH 1 Inhibitor
- IDH 2 Inhibitor
- MEK Inhibitor
- NTRK Inhibitor
- PARP Inhibitor
- PIK3CA Inhibitor
- ROS1 Inhibitor
- SHH Pathway Inhibitor
- VEGF Inhibitor
- Decoy VEGF Receptor
- Coagulopathy
- Anticoagulation
- Emergent Reversal of Anticoagulation
- Prothrombin Complex Concentrate
- Tranexamic Acid
- Unfractionated Heparin
- Heparin Induced Thrombocytopenia
- Protamine
- Anticoagulation in Thromboembolism
- Low Molecular Weight Heparin
- Dalteparin
- Enoxaparin
- Direct Thrombin Inhibitor
- Idarucizumab
- Argatroban
- Bivalirudin
- Dabigatran
- Desirudin
- Ximelagatran
- Thrombolytic
- MI Thrombolysis
- Thrombolysis in Massive Pulmonary Embolism
- CVA Thrombolysis
- Recombinant Staphylokinase
- Streptokinase
- Tissue Plasminogen Activator
- Tenecteplase
- Warfarin
- Warfarin Drug Interactions
- Warfarin Protocol
- Factor Xa Inhibitor
- Andexxa
- Apixaban
- Edoxaban
- Fondaparinux
- Rivaroxaban
- Hemolytic Disorders
- Drug-Induced Hemolytic Anemia
- Medications in G6PD Deficiency
- Pathology and Laboratory Medicine
- Medication Causes of Neutropenia
- Lymphatic Disorders
- Medication Causes of Lymphadenopathy
- Bone Marrow Disorders
- Filgrastim
- Pegfilgrastim
- Sargramostim
- Platelet Disorders
- Drug Induced Platelet Dysfunction
- Antiplatelet Therapy for Vascular Disease
- Antiplatelet Management in Diabetes Mellitus
- Platelet ADP Receptor Antagonist
- Cangrelor
- Clopidogrel
- Prasugrel
- Ticagrelor
- Ticlopidine
- Glycoprotein IIB/IIIA Inhibitor
- Abciximab
- Eptifibatide
- Tirofiban
- Vorapaxar
- Cilostazol
- Dipyridamole
- Pentoxifylline
- Blood Transfusion
- Transfusion Complication
- Allergic Transfusion Reaction
- Transfusion Associated Circulatory Overload
- Febrile Nonhemolytic Transfusion Reaction
- Transfusion Associated Graft Versus Host Disease
- Transfusion-Related Acute Lung Injury
- Cryoprecipitate
- Fibrinogen Concentrate
- Plasma Transfusion
- Platelet Transfusion
- Blood Transfusion
- Transfusion Hemolysis
- Massive Blood Transfusion
- Hematopoietic Stem Cell Transplant
- Bone Marrow Transplant
From Related Chapters
II. Advantages
III. Disadvantages
- Biological product generates immune response
- May only be able to administer once
IV. References
Images: Related links to external sites (from Bing)
These images are a random sampling from a Bing search on the term "Recombinant Staphylokinase." Click on the image (or right click) to open the source website in a new browser window. Search Bing for all related images
Related Studies
Related Topics in Pharmacology
Cardiovascular Medicine Book
Dentistry Book
Dermatology Book
Emergency Medicine Book
Endocrinology Book
Gastroenterology Book
Geriatric Medicine Book
Gynecology Book
Hematology and Oncology Book
Human Immunodeficiency Virus Book
Infectious Disease Book
Jokes Book
Mental Health Book
Neonatology Book
Nephrology Book
Neurology Book
Obstetrics Book
Ophthalmology Book
Orthopedics Book
Otolaryngology Book
Pathology and Laboratory Medicine Book
Pediatrics Book
Pharmacology Book
Practice Management Book
Prevention Book
Pulmonology Book
Radiology Book
Rheumatology Book
Sports Medicine Book
Surgery Book
Urology Book
Anatomy Chapter
Anemia Chapter
Bone Marrow Disorders Chapter
Cancer Chapter
Cardiovascular Medicine Chapter
Coagulopathy Chapter
Dermatology Chapter
Endocrinology Chapter
Examination Chapter
Gastroenterology Chapter
General Chapter
Geriatric Medicine Chapter
Hemoglobinopathies Chapter
Hemolytic Disorders Chapter
Human Immunodeficiency Virus Chapter
Infectious Disease Chapter
Leukemias Chapter
Lymphatic Disorders Chapter
Mental Health Chapter
Neurology Chapter
Obstetrics Chapter
Orthopedics Chapter
Otolaryngology Chapter
Pathology and Laboratory Medicine Chapter
Pediatrics Chapter
Pharmacology Chapter
Platelet Disorders Chapter
Practice Management Chapter
Prevention Chapter
Procedure Chapter
Pulmonology Chapter
Radiology Chapter
Rheumatology Chapter
Sarcomas Chapter
Surgery Chapter
Symptoms Chapter
Abciximab
Abiraterone
Albumin-Bound Paclitaxel
ALK Inhibitor
Alkylating Agent
Allergic Transfusion Reaction
Andexxa
Antibiotic Chemotherapy
Anticoagulation
Anticoagulation in Thromboembolism
Anti-HER2 Monoclonal Antibody
Antimetabolite Chemotherapy
Antiplatelet Management in Diabetes Mellitus
Antiplatelet Therapy for Vascular Disease
Apixaban
Argatroban
Arsenic Trioxide
Asparaginase
Azacitidine
BCL2 Inhibitor
BCR-ABL Inhibitor
Belinostat
Bendamustine
Bexarotene
Bivalirudin
Bleomycin
Blood Transfusion
Bone Marrow Transplant
BRAF Inhibitor
BTK Inhibitor
Busulfan
Cabazitaxel
Cangrelor
Capecitabine
CAR T-Cell Therapy
Carboplatin
Carmustine
CCR4 Monoclonal Antibody
CD20 Monoclonal Antibody
CD22 Monoclonal Antibody
CD25 Monoclonal Antibody
CD30 Monoclonal Antibody
CD33 Monoclonal Antibody
CD38 Monoclonal Antibody
CD52 Monoclonal Antibody
Chemotherapy
Chlorambucil
Cilostazol
Cisplatin
c-KIT Inhibitor
Cladribine
Clofarabine
Clopidogrel
Cryoprecipitate
CTLA-4 Monoclonal Antibody
CVA Thrombolysis
Cyclin-Dependent Kinase Inhibitor
Cyclophosphamide
Cytarabine
Cytokine Release Syndrome
Dabigatran
Dacarbazine
Dactinomycin
Dalteparin
Darbepoetin Alfa
Daunorubicin
Decitabine
Decoy VEGF Receptor
Desirudin
Dipyridamole
Direct Thrombin Inhibitor
Docetaxel
Doxorubicin
Drug Induced Platelet Dysfunction
Drug-Induced Hemolytic Anemia
Edoxaban
EGFR Inhibitor
EGFR Monoclonal Antibody
Emergent Reversal of Anticoagulation
Enoxaparin
Epirubicin
Epoetin Alfa
Eptifibatide
Eribulin
Erythropoietin
Etoposide
Factor Xa Inhibitor
Febrile Nonhemolytic Transfusion Reaction
FGR2/3 Inhibitor
Fibrinogen Concentrate
Filgrastim
Floxuridine
FLT3 Inhibitor
Fludarabine
Fluorouracil
Fondaparinux
GD2 Monoclonal Antibody
Gemcitabine
Glycoprotein IIB/IIIA Inhibitor
Hematopoietic Stem Cell Transplant
Heparin Induced Thrombocytopenia
Hormonally Active Chemotherapy
Hydroxyurea
Idarubicin
Idarucizumab
IDH 1 Inhibitor
IDH 2 Inhibitor
Ifosfamide
Immune Checkpoint Inhibitor
Irinotecan
Irinotecan Liposome
Iron Ingestion
Iron Supplementation
Ixabepilone
Liposomal Doxorubicin
Lomustine
Low Molecular Weight Heparin
Massive Blood Transfusion
Mechlorethamine
Medication Causes of Lymphadenopathy
Medication Causes of Macrocytic Anemia
Medication Causes of Neutropenia
Medications in G6PD Deficiency
MEK Inhibitor
Melphalan
Mercaptopurine
Methoxy Polyethyelene Glycol Epoetin Beta
MI Thrombolysis
Mitomycin
Mitotane
Mitotic Inhibitor Chemotherapy
Mitoxantrone
Monoclonal Antibody-Mediated Chemotherapy
Nelarabine
Nonsteroidal Antiandrogen
NTRK Inhibitor
Oxaliplatin
Paclitaxel
Panobinostat
Parenteral Iron
PARP Inhibitor
PD-1 Monoclonal Antibody
PDL-1 Monoclonal Antibody
Pegfilgrastim
Pemetrexed
Pentostatin
Pentoxifylline
PIK3CA Inhibitor
Plasma Transfusion
Platelet ADP Receptor Antagonist
Platelet Transfusion
Porfimer
Pralatrexate
Prasugrel
Procarbazine
Protamine
Proteasome Inhibitor
Prothrombin Complex Concentrate
Recombinant Staphylokinase
Rituximab
Rivaroxaban
Romidepsin
ROS1 Inhibitor
Sargramostim
SHH Pathway Inhibitor
Small Molecule Inhibitor-Mediated Chemotherapy
Streptokinase
Streptozocin
Systemic Tretinoin
Targeted Cancer Therapy
Temozolomide
Tenecteplase
Thalidomide
Thioguanine
Thiotepa
Thrombolysis in Massive Pulmonary Embolism
Thrombolytic
Ticagrelor
Ticlopidine
Tirofiban
Tissue Plasminogen Activator
Topotecan
Trabectedin
Tranexamic Acid
Transfusion Associated Circulatory Overload
Transfusion Associated Graft Versus Host Disease
Transfusion Complication
Transfusion Hemolysis
Transfusion-Related Acute Lung Injury
Trifluridine-Tipiracil
Tumor Lysis Syndrome
Unfractionated Heparin
Valrubicin
VEGF Inhibitor
VEGFR Monoclonal Antibody
Vinblastine
Vincristine
Vincristine Sulfate Liposome
Vinorelbine
Vitamin B12 Supplementation
Vorapaxar
Vorinostat
Warfarin
Warfarin Drug Interactions
Warfarin Protocol
Ximelagatran